FDA Approved: NUZYRA — Supplemental Application (Paratek Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved a supplemental application for NUZYRA (omadacycline) to modify the labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Skin and Skin Structure Infection
• Community-acquired Bacterial Pneumonia

Drugs mentioned

• Nuzyra (Omadacycline)

Snippet

SUPPL AP for NUZYRA (OMADACYCLINE)